A first-in-human study to learn about the safety of BAY 3547926 and how well it works in participants with advanced liver cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516615-25-00

Acronym

22262

Enrollment

Registered

2025-04-08

Start date

2025-05-14

Completion date

Unknown

Last updated

2025-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma (HCC)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Finland, France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026